Generex Biotechnology Corporation

OTCPK:GNBT Stock Report

Market Cap: US$61.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Generex Biotechnology Past Earnings Performance

Past criteria checks 0/6

Key information

-40.9%

Earnings growth rate

8.5%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate-65.8%
Return on equityn/a
Net Margin-5,378.7%
Last Earnings Update30 Apr 2021

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Generex Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:GNBT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Apr 211-37305
31 Jan 211-52284
31 Oct 202-35263
31 Jul 203-33182
30 Apr 202-26232
31 Jan 203-31252
31 Oct 195-36272
31 Jul 196-9252
30 Apr 19610152
31 Jan 19524101
31 Oct 1822741
31 Jul 1813621
30 Apr 181921
31 Jan 181-3721
31 Oct 170-4311
31 Jul 170-7010
30 Apr 170-6010
31 Jan 170-1700
31 Oct 160-100
31 Jul 160-310
30 Apr 160-221
31 Jan 160-421
31 Oct 150-431

Quality Earnings: GNBT is currently unprofitable.

Growing Profit Margin: GNBT is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if GNBT's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare GNBT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: GNBT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (96.9%).


Return on Equity

High ROE: GNBT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.